Antimicrobial paint for hospitals is getting fresh attention this year. New CDC data released this summer brought welcome news: healthcare-associated infections (HAIs) are declining across US hospitals. In 2023, about 1 in 38 hospitalized patients had at least one HAI on any given day, down from 1 in 31 in 2015. Published in The New England Journal of Medicine, the survey credits tighter federal quality reporting, better antibiotic stewardship, and improved infection control practices for the drop. It is genuinely good progress, but the same data set has a number that deserves just as much attention: an estimated 518,000 HAIs still occurred in US hospitals in 2023, and 61% of them were not linked to any medical device or procedure at all. That statistic points squarely at the built environment: the walls, rails, furniture, and fixtures patients and staff touch every day.
What the New CDC Numbers Actually Show
The 2023 Emerging Infections Program survey covered 13,653 patients across 218 hospitals in 10 states. The encouraging parts: central line-associated bloodstream infections, catheter-associated urinary tract infections, and Clostridioides difficile infections all showed significant reductions, consistent with years of national prevention effort. The less encouraging part: rates of surgical site infections and pneumonia barely moved, and CDC officials were explicit that more needs to be done. With well over half of all HAIs unconnected to a device or procedure, hospitals are increasingly looking beyond hand hygiene and terminal cleaning schedules toward the surfaces themselves.
Cleaning Protocols Are Not the Whole Story
Standard cleaning and disinfection remain the foundation of infection control, and nothing should replace them. But a disinfected surface only stays that way for as long as it takes the next person to touch it. In a busy ward, that can be minutes. Door handles, bed rails, nurse call buttons, waiting room chairs, and reception counters get recontaminated constantly between scheduled cleaning rounds, the exact gap where the 61% of “non-device” HAIs likely take root.
This is precisely the category the US EPA has carved out as a Supplemental Residual Antimicrobial Product (SRAP): a product designed to sit alongside routine cleaning and disinfection, adding a layer of protection in the hours and days between them, not a disinfectant, and not a substitute for either.
Where Antimicrobial Paint for Hospitals Fits In
For walls and ceilings, some of the largest surface areas in any patient room, corridor, or waiting area, VireXbuster Wall is a waterborne antimicrobial paint applied exactly like a standard white interior coat, with no special equipment or downtime beyond a normal repaint. It uses a hybrid formulation with a very wide spectrum of activity against viruses, bacteria, fungi, mold, and mildew, and it is BAuA approved, Fraunhofer tested, QualityLabs certified as antimicrobial, and Dermatest certified “Excellent” for dermatological safety, relevant credentials in a clinical setting where patients and staff are in constant contact with painted surfaces.
For Surfaces That Cannot Be Repainted
Metal bed rails, plastic furniture, equipment housings, and other hard or soft surfaces that are not practical to repaint can instead be treated with VireXbuster Spray, a sprayable antimicrobial coating that gives existing surfaces up to 12 months of protection per application. It is already used across hospitals, offices, transport, and other public spaces where high-touch fixtures need ongoing coverage.
For Facilities That Manufacture Their Own Fixtures
Furniture makers and medical equipment manufacturers supplying hospitals can build the same protection in at the source with VireXbuster 4Bulk, an additive mixed directly into plastic pellets during extrusion or injection molding. Stable to 300°C, it gives finished polymer products, including polymer flooring, years of embedded protection without any coating step.
A Layer, Not a Replacement
None of this changes what CDC and CMS require: hand hygiene, terminal cleaning, and device-specific infection bundles remain the backbone of any infection prevention program. What antimicrobial coatings add is coverage in the gaps between those interventions, on the surfaces that make up the other 61%.
FAQ
Is VireXbuster a disinfectant?
No. VireXbuster is not a disinfectant. In the US, the EPA classifies this product category as a Supplemental Residual Antimicrobial Product (SRAP), designed to work alongside standard cleaning and disinfection, not replace it.
Can antimicrobial wall paint replace a hospital’s cleaning protocol?
No. It is a supplemental, residual layer of protection for the time between scheduled cleanings, not a substitute for CDC- or CMS-mandated infection control practices.
Where can I see the full VireXbuster product range?
VireXbuster Spray, VireXbuster Wall, and VireXbuster 4Bulk are all detailed at https://www.virexbuster.de/shop.
